SCHEMBL218118

SCHEMBL218118

c1ccc(-c2ccn(-c3ccccc3)n2)cc1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 3/20 0.57
HTT P42858 2/20 0.51
CYP2C9 P11712 1/20 0.46
HPGD P15428 2/20 0.45
ALDH1A1 P00352 4/20 0.44
MAPT P10636 2/20 0.44
HSD17B10 Q99714 2/20 0.44
KDM4E B2RXH2 1/20 0.44
ALOX15 P16050 1/20 0.44
MAPK1 P28482 1/20 0.44
MCL1 Q07820 1/20 0.44
TDP1 Q9NUW8 1/20 0.44
TSHR P16473 3/20 0.43
L3MBTL1 Q9Y468 1/20 0.43
RAB9A P51151 3/20 0.41
SMN1; SMN2 Q16637 2/20 0.41
MEN1 O00255 2/20 0.41
PTGS2 P35354 1/20 0.41
GFER P55789 1/20 0.41
ADORA3 P0DMS8 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Ammonia Solution, Strong SCHEMBL10418488 0.98 KMT2A (0.55) KMT2AHTTCYP2C9HPGDALDH1A1
SCHEMBL17279816 0.90 KMT2A (0.52) KMT2AHTTCYP2C9HPGDALDH1A1
SCHEMBL17279826 0.90 ALDH1A1 (0.48) KMT2AHTTCYP2C9HPGDALDH1A1
Formamide SCHEMBL29227819 0.89 HTT (0.48) KMT2AHTTCYP2C9HPGDALDH1A1
SCHEMBL15072164 0.88 KMT2A (0.50) KMT2AHTTCYP2C9HPGDALDH1A1
SCHEMBL2148390 0.88 ALDH1A1 (0.46) KMT2AHTTCYP2C9HPGDALDH1A1
SCHEMBL13679138 0.87 HTT (0.65) KMT2AHTTCYP2C9HPGDALDH1A1
SCHEMBL4308671 0.87 KMT2A (0.48) KMT2AHTTCYP2C9ALDH1A1SMN1; SMN2
SCHEMBL15060395 0.87 NPC1 (0.50) KMT2AHTTALDH1A1MAPTKDM4E
SCHEMBL29007611 0.87 HTT (0.65) KMT2AHTTCYP2C9HPGDALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 349 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12617771-B2 Diphenylpyrazole compound, and preparation method therefor and application thereof NORTHWEST A&F UNIVERSITY (CN) 2026-05-05 US claimed
CN-119055639-A Application of diphenylpyrazole compound in preparation of medicine for treating tuberculosis 西北农林科技大学 2024-12-03 CN claimed
CN-118678881-A Application of diphenylpyrazole compound as herbicide synergist 西北农林科技大学 2024-09-20 CN claimed
CN-118591293-A Weeding composition 西北农林科技大学 2024-09-03 CN claimed
US-20240083871-A1 DIPHENYLPYRAZOLE COMPOUND, AND PREPARATION METHOD THEREFOR AND APPLICATION THEREOF NORTHWEST A&F UNIVERSITY (CN) 2024-03-14 US claimed
CN-117658918-A Application of diphenylpyrazole compound 西北农林科技大学 2024-03-08 CN claimed
CN-114716409-B Diphenyl pyrazole compound and preparation method and application thereof 西北农林科技大学 2024-01-12 CN claimed
WO-2023202545-A1 USE OF DIPHENYL PYRAZOLE COMPOUND AS HERBICIDE SYNERGIST 西北农林科技大学 2023-10-26 WO claimed
CN-112724086-B Preparation method of 5-amino-4-nitrile-1, 3-diphenylpyrazole 三峡大学 2022-09-02 CN claimed
CN-114716409-A Diphenyl pyrazole compound and preparation method and application thereof 西北农林科技大学 2022-07-08 CN claimed
EP-1713484-A2 COMPOUNDS AND METHODS OF USE AMGEN INC. (US) 2006-10-25 EP claimed
EP-1711495-A2 QUINOLINE, QUINAZOLINE, PYRIDINE AND PYRIMIDINE COUNDS AND THEIR USE IN THE TREATMENT OF INFLAMMATION, ANGIOGENESIS AND CANCER AMGEN INC. (US) 2006-10-18 EP claimed
US-20050245547-A1 6-((6,7-Bis(methoxy)-4-quinolinyl)oxy)-N-(3-methylphenyl)-1-benzofuran-3-carboxamide;antiproliferative; -metastasis; -carcinogenic; -tumor; -inflammatory; -arthritic agents;hypotensive agents; myocardium necrosis; rheumatic diseases; tyrosine kinase inhibitors; antiallergens; asthma AMGEN INC. 2005-11-03 US claimed
WO-2005073224-A2 QUINOLINE QUINAZOLINE PYRIDINE AND PYRIMIDINE COUNDS AND THEIR USE IN THE TREATMENT OF INFLAMMATION ANGIOGENESIS AND CANCER AMGEN INC (US) 2005-08-11 WO claimed
WO-2005070891-A2 COMPOUNDS AND METHODS OF USE AMGEN INC (US) 2005-08-04 WO claimed
EP-1141207-B1 TRANSPARENT/TRANSLUCENT LIQUID ENZYME COMPOSITIONS IN CLEAR BOTTLES COMPRISING FLUORESCENT DYE OR UV ABSORBER UNILEVER NV (NL) 2004-02-04 EP claimed
EP-1141213-B1 TRANSPARENT/TRANSLUCENT LIQUID COMPOSITIONS IN CLEAR BOTTLES COMPRISING COLORANT AND FLUORESCENT DYE OR UV ABSORBER UNILEVER NV (NL) 2004-02-04 EP claimed
EP-1047729-B1 COMPOSITION FOR BLEACHING MECHANICAL PULP DE DONATO FAUSTO (IT) 2003-01-08 EP claimed
EP-0731796-A1 1,3,5-TRISUBSTITUTED PYRAZOLE COMPOUNDS FOR TREATMENT OF INFLAMMATION G.D. SEARLE & CO. (US) 1996-09-18 EP claimed
WO-1995015318-A1 1,3,5-TRISUBSTITUTED PYRAZOLE COMPOUNDS FOR TREATMENT OF INFLAMMATION G.D. SEARLE & CO. (US) 1995-06-08 WO claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050245547-A1 6-((6,7-Bis(methoxy)-4-quinolinyl)oxy)-N-(3-methylphenyl)-1-benzofuran-3-carboxamide;antiproliferative; -metastasis; -carcinogenic; -tumor; -inflammatory; -arthritic agents;hypotensive agents; myocardium necrosis; rheumatic diseases; tyrosine kinase inhibitors; antiallergens; asthma HGF, MET, HGFAC KMT2A 2053/4885HTT 1534/4885CYP2C9 1651/4885
US-12617771-B2 Diphenylpyrazole compound, and preparation method therefor and application thereof GSTP1, GSTO1, GSTA1 KMT2A 4050/4885HTT 4506/4885CYP2C9 89/4885
US-20240083871-A1 DIPHENYLPYRAZOLE COMPOUND, AND PREPARATION METHOD THEREFOR AND APPLICATION THEREOF GSTP1, CYP4F11, GSTA1 KMT2A 3071/4885HTT 4122/4885CYP2C9 49/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.